Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ASPC | A Spac III Acquisition Corp. | $35.06 | $21.64 | 161.25% | 4.8M | $31M | $9.95$63.98 |
| GSIT | Gsi Technology | $8.14 | $2.08 | 34.32% | 204.8K | $214M | $1.62$18.15 |
| GLTO | Galecto | $36.30 | $6.81 | 23.09% | 111.7K | $47M | $2.01$37.63 |
| RAY | Raytech | $2.35 | $0.42 | 21.50% | 174.4K | $5.3M | $1.40$58.88 |
| SHMD | Schmid Group | $6.03 | $1.01 | 20.12% | 11.2K | $244M | $1.86$6.70 |
| GLSI | Greenwich LifeSciences | $20.52 | $3.31 | 19.23% | 916.1K | $238M | $7.78$22.31 |
| JLHL | Julong | $4.34 | $0.65 | 17.61% | 62.5K | $78M | $2.70$6.30 |
| QBTZ | Tidal Trust II - Defiance Daily Target 2x Short Qbts ETF | $10.43 | $1.56 | 17.59% | 3.5M | - | $6.62$32.28 |
| UPC | Universe Pharmaceuticals Inc | $4.98 | $0.70 | 16.22% | 3.1M | $2.4M | $2.51$28.00 |
| EDAP | Edap Tms | $3.39 | $0.42 | 14.21% | 50.9K | $111M | $1.21$3.45 |
Related Articles
Featured Article
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Advertisement